Item 2.02 Results of Operations and Financial Condition.

On February 28, 2013, Nektar Therapeutics, a Delaware corporation ("Nektar"), issued a press release (the "Press Release") announcing its financial results for the quarter and year ended December 31, 2012. A copy of the Press Release is furnished herewith as Exhibit 99.1.

On February 13, 2013, Nektar announced that it would hold a Webcast conference call on February 28, 2013 to review its financial results for the quarter and year ended December 31, 2012. This conference call is accessible through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com.

The information in this report, including the exhibit hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by Nektar Therapeutics, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit
No. Description

99.1 Press release titled "Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results" issued by Nektar Therapeutics on February 28, 2013.